中文版 | English

在结果中检索

CSpace

浏览/检索结果: 共2条，第1-2条 帮助

限定条件            
已选(0)清除 条数/页：   排序方式：
High Throughput Transcriptome Data Analysis and Computational Verification Reveal Immunotherapy Biomarkers of Compound Kushen Injection for Treating Triple-Negative Breast Cancer 期刊论文
FRONTIERS IN ONCOLOGY, 2021, 卷号: 11, 页码: 23
作者:  Liu, Xinkui;  Wu, Yang;  Zhang, Yingying;  Bu, Dechao;  Wu, Chao;  Lu, Shan;  Huang, Zhihong;  Song, Yurong;  Zhao, Yi;  Guo, Fengying;  Ye, Peizhi;  Fu, Changgeng;  Shen, Liangliang;  Zhang, Jingyuan;  Wang, Haojia;  Duan, Xianchun;  Wu, Jiarui
收藏  |  浏览/下载：29/0  |  提交时间：2022/06/21
compound kushen injection  triple-negative breast cancer  RNA sequencing  tumor microenvironment  prognostic signature  
DAGM: A novel modelling framework to assess the risk of HER2-negative breast cancer based on germline rare coding mutations 期刊论文
EBIOMEDICINE, 2021, 卷号: 69, 页码: 11
作者:  Yang, Mei;  Fan, Yanhui;  Wu, Zhi-Yong;  Gu, Jin;  Feng, Zhendong;  Zhang, Qiangzu;  Han, Shunhua;  Zhang, Zhonghai;  Li, Xu;  Hsueh, Yi-Ching;  Ni, Yanxiang;  Li, Xiaoling;  Li, Jieqing;  Hu, Meixia;  Li, Weiping;  Gao, Hongfei;  Yang, Ciqiu;  Zhang, Chunming;  Zhang, Liulu;  Zhu, Teng;  Cheng, Minyi;  Ji, Fei;  Xu, Juntao;  Cui, Hening;  Tan, Guangming;  Zhang, Michael Q.;  Liang, Changhong;  Liu, Zaiyi;  Song, You-Qiang;  Niu, Gang;  Wang, Kun
收藏  |  浏览/下载：40/0  |  提交时间：2021/12/01
HER2-negative breast cancer  Germline rare coding mutations  Damage assessment of genomic mutations (DAGM)  Risk assessment  Activity profiles of signalling pathways (APSP)  HER2 signalling pathway  Immune suppression